TY - JOUR
T1 - Sinusoidal CO2 respiratory challenge for concurrent perfusion and cerebrovascular reactivity MRI
AU - Vu, Chau
AU - Xu, Botian
AU - González-Zacarías, Clio
AU - Shen, Jian
AU - Baas, Koen P. A.
AU - Choi, Soyoung
AU - Nederveen, Aart J.
AU - Wood, John C.
N1 - Funding Information:
This work was supported by National Heart, Lung, and Blood Institute (grant 1U01-HL-117718-01, 1R01-HL136484-01A1), the National Center for Research (5UL1-TR000130-05) through the Clinical Translational Science Institute at Children’s Hospital Los Angeles, the National Institutes of Health (grant R01-NS074980), and the National Institute of Neurological Disorders and Stroke (grant 1F31NS106828‐01A1). CV was supported by the Core Pilot Program and a Research Career Development Fellowship from the Saban Research Institute at Children’s Hospital Los Angeles. Philips Healthcare provided support for protocol development and applications engineering on a support-in-kind basis.
Publisher Copyright:
Copyright © 2023 Vu, Xu, González-Zacarías, Shen, Baas, Choi, Nederveen and Wood.
PY - 2023/2/9
Y1 - 2023/2/9
N2 - Introduction: Deoxygenation-based dynamic susceptibility contrast (dDSC) has previously leveraged respiratory challenges to modulate blood oxygen content as an endogenous source of contrast alternative to gadolinium injection in perfusion-weighted MRI. This work proposed the use of sinusoidal modulation of end-tidal CO2 pressures (SineCO2), which has previously been used to measure cerebrovascular reactivity, to induce susceptibility-weighted gradient-echo signal loss to measure brain perfusion. Methods: SineCO2 was performed in 10 healthy volunteers (age 37 ± 11, 60% female), and tracer kinetics model was applied in the frequency domain to calculate cerebral blood flow, cerebral blood volume, mean transit time, and temporal delay. These perfusion estimates were compared against reference techniques, including gadolinium-based DSC, arterial spin labeling, and phase contrast. Results: Our results showed regional agreement between SineCO2 and the clinical comparators. SineCO2 was able to generate robust CVR maps in conjunction to baseline perfusion estimates. Discussion: Overall, this work demonstrated feasibility of using sinusoidal CO2 respiratory paradigm to simultaneously acquire both cerebral perfusion and cerebrovascular reactivity maps in one imaging sequence.
AB - Introduction: Deoxygenation-based dynamic susceptibility contrast (dDSC) has previously leveraged respiratory challenges to modulate blood oxygen content as an endogenous source of contrast alternative to gadolinium injection in perfusion-weighted MRI. This work proposed the use of sinusoidal modulation of end-tidal CO2 pressures (SineCO2), which has previously been used to measure cerebrovascular reactivity, to induce susceptibility-weighted gradient-echo signal loss to measure brain perfusion. Methods: SineCO2 was performed in 10 healthy volunteers (age 37 ± 11, 60% female), and tracer kinetics model was applied in the frequency domain to calculate cerebral blood flow, cerebral blood volume, mean transit time, and temporal delay. These perfusion estimates were compared against reference techniques, including gadolinium-based DSC, arterial spin labeling, and phase contrast. Results: Our results showed regional agreement between SineCO2 and the clinical comparators. SineCO2 was able to generate robust CVR maps in conjunction to baseline perfusion estimates. Discussion: Overall, this work demonstrated feasibility of using sinusoidal CO2 respiratory paradigm to simultaneously acquire both cerebral perfusion and cerebrovascular reactivity maps in one imaging sequence.
KW - brain perfusion
KW - carbon dioxide challenge
KW - cerebrovascular reactivity (CVR)
KW - deoxygenation
KW - dynamic susceptibility contrast (DSC)
KW - respiratory challenges
UR - https://www.scopus.com/pages/publications/85148606707
U2 - 10.3389/fphys.2023.1102983
DO - 10.3389/fphys.2023.1102983
M3 - Article
C2 - 36846345
SN - 1664-042X
VL - 14
JO - Frontiers in physiology
JF - Frontiers in physiology
M1 - 1102983
ER -